Novozymes reported 244.9M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Arq USD 4.75M 1.76M Mar/2026
Avient USD 190M 12.2M Dec/2025
Chemours USD 469M 322M Jun/2026
Coronado Global Resources USD 90.35M 1.18M Mar/2026
Corteva USD 1.16B 287M Jun/2026
Metallus USD 22.3M 2.2M Dec/2025
Newmont Corporation USD 79M 7M Mar/2026
Novozymes 244.9M 4.8M Mar/2026
SSR Mining USD 27.65M 10.83M Jun/2026